Login

Camino a la excelencia translates to "Pathway to excellence." 00:10:00

Share On Facebook Share On Twitter

Tomas Cordoba - CEO - MetroGAS

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Ben Kirin on J.G. Ballard's 'Crash' and Its Dark Fascination|Benjamin Kerstein, Professor, Ben-Gurion University
00:10:00
Understanding Investor Behavior: Fuller & Thaler's Contrarian and Reactionary Investment Strategies
00:10:00
leading investments in transformative companies building in future|Paul Hsiao,General Partner,Canvas Ventures
00:10:00
Investing arm within Clocktower Group, Clocktower Technology Ventures partners with phenomenal entrepreneurs|Steve Drobny,Founder and CEO,Clocktower Technology Ventures
00:10:00
Michael Moe on the Rise of SPACs and GSV's Recent CLASS IPO in Digital Learning
00:10:00
Meet Jeff Chan: Transitioning from Chemical Engineering to Empowering Financial Futures
00:10:00
Video-Sharing Wealth Group: Comprehensive, Fee-Only Financial Planning
00:10:00
Decades of Market Wisdom: Tangu Tan's Insights on Malaysia's Economic Landscape | Tan Teng Boo, CEO ,  Capital Dynamics.
00:10:00
"York Capital Management CEO Jamie Dinan announces plans to wind down most of the firm's hedge funds in a letter to investors, as reported by CNBC's Leslie Picker."
00:10:00
Q3 2024 Earnings GTM strategy | Samuel Wilson, CEO, 8x8 IncEGHT:NSQ
00:10:00
James Dickson, CEO of Vianet Group plc (LON), presents at the Virtual Growth & Innovation Forum, highlighting the company's diverse portfolio.|James Dickson, CEO of Vianet Group plc
00:10:00
ConocoPhillips: Navigating Global Energy Frontiers with a Diverse Portfolio | Will Giraud, Senior Vice President of ConocoPhillips Company

© 2026 Nehu